COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and CEO, is scheduled to present at ThinkEquity’s Sixth Annual Growth Conference: G6, Thursday September 17, 2009 at 12:30 p.m. EDT. Dr. Mills is also scheduled to present at the UBS Global Life Sciences Conference in on Monday, September 21, 2009 at 9:30 a.m. EDT.
